These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium. Mistry A; Stolnik S; Illum L Mol Pharm; 2015 Aug; 12(8):2755-66. PubMed ID: 25997083 [TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles. Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293 [TBL] [Abstract][Full Text] [Related]
11. Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application. Yoncheva K; Vandervoort J; Ludwig A Pharm Dev Technol; 2011 Feb; 16(1):29-35. PubMed ID: 20038266 [TBL] [Abstract][Full Text] [Related]
12. Revisiting the role of sucrose in PLGA-PEG nanocarrier for potential intranasal delivery. Bonaccorso A; Musumeci T; Carbone C; Vicari L; Lauro MR; Puglisi G Pharm Dev Technol; 2018 Mar; 23(3):265-274. PubMed ID: 28128676 [TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E. Kuo YC; Rajesh R Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973 [TBL] [Abstract][Full Text] [Related]
14. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder. Bari NK; Fazil M; Hassan MQ; Haider MR; Gaba B; Narang JK; Baboota S; Ali J Int J Biol Macromol; 2015 Nov; 81():49-59. PubMed ID: 26210037 [TBL] [Abstract][Full Text] [Related]
15. Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? Tosi G; Badiali L; Ruozi B; Vergoni AV; Bondioli L; Ferrari A; Rivasi F; Forni F; Vandelli MA Nanomedicine (Lond); 2012 Mar; 7(3):365-82. PubMed ID: 21957863 [TBL] [Abstract][Full Text] [Related]
16. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ". Shah B; Khunt D; Misra M; Padh H Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654 [TBL] [Abstract][Full Text] [Related]
17. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. Kumar MN; Mohapatra SS; Kong X; Jena PK; Bakowsky U; Lehr CM J Nanosci Nanotechnol; 2004 Nov; 4(8):990-4. PubMed ID: 15656192 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
19. Mixed Amphiphilic Polymeric Nanoparticles of Chitosan, Poly(vinyl alcohol) and Poly(methyl methacrylate) for Intranasal Drug Delivery: A Preliminary In Vivo Study. Schlachet I; Moshe Halamish H; Sosnik A Molecules; 2020 Sep; 25(19):. PubMed ID: 33008001 [TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]